The "ERA 2024" brings you a packed program; catch up on the key breakthrough data from the experts. Plus, the grand finale includes a Roundtable Discussion, where experts will update on key new data and how it might impact your region.
Explore the latest updates on diabetic nephropathy, highlighting its significance in the context of chronic kidney disease (CKD) as a pressing global health concern. Delve into the therapeutic potential of SGLT2 inhibition for managing cardiorenal disease, and gain insights from nephrology and cardiology perspectives on heart failure with preserved ejection fraction (HFpEF). Additionally, discover current insights on the etiology and treatment of focal segmental glomerulosclerosis (FSGS), along with effective management strategies for hyperkalemia (HK).

Speakers:
Prof Meg Jardine, MD, PhD (MODERATOR)
Prof Roberto Pecoits – Filho, MD, PhD
Prof Olynka Vega, MD, PhD.
Akira Wu, MD.
Prof. Sydney Tang
Roundtable Discussion Part 1
TH-18480
Roundtable Discussion Part 2
TH-18481
Roundtable Discussion Part 3
TH-18482
ERA 2024 Highlights :
| Topic | speakers | ||
| 1 | Late breaking trial: FLOW study and clinical interpretation | Prof. Mustafa Jamal Ahmed, MD, PhD. | [watch now] |
| 2 | SGLT2i in CKD Management | Prof. Mustafa Jamal Ahmed, MD, PhD. | [watch now] |
| 3 | Anemia in CKD | Prof. Mustafa Jamal Ahmed, MD, PhD. | [watch now] |
| 4 | FSGS: current thoughts on etiology and treatment | Prof. Mustafa Jamal Ahmed, MD, PhD. | [watch now] |
| 5 | SGLT2i for Cardio-Renal Disease | Prof. Khaled Mahmoud, MD, PhD. | [watch now] |
| 6 | CKD as a Global Health Issue | Prof. Khaled Mahmoud, MD, PhD. | [watch now] |
| 7 | Diabetic Update | Dr. Shyam Bihari Bansal MD, DM, FISN, FISOT, FASN, FRCP | [watch now] |
| 8 | Hypertension Nephropathy Update | Dr. Shyam Bihari Bansal MD, DM, FISN, FISOT, FASN, FRCP | [watch now] |
| 9 | IgAN: What is the current status and the advances in the treatment? | Dr. Shyam Bihari Bansal MD, DM, FISN, FISOT, FASN, FRCP | [watch now] |
| 10 | Hyperkalemia management and CKM syndrome | Dinesh Khullar, MD. | [watch now] |
| 11 | The HIF-PHI: Updates on a novel therapy of Renal Anemia | Dinesh Khullar, MD. | [watch now] |
Late breaking trial: FLOW study and clinical interpretation
TH-18568
SGLT2i in CKD Management
TH-18569
Anemia in CKD
TH-18570
FSGS: current thoughts on etiology and treatment
TH-18571
SGLT2i for Cardio-Renal Disease
TH-18563
CKD as a Global Health Issue
TH-18566
Diabetic Update
TH-18567
Hypertension Nephropathy Update
TH-18575
IgAN: What is the current status and the advances in the treatment?
TH-18576
Hyperkalemia management and CKM syndrome
TH-18572
The HIF-PHI: Updates on a novel therapy of Renal Anemia
TH-18573
TH-18425
EXP 21 May 2026